OBJECTIVES: Polycystic ovary syndrome (PCOS) is one of the most common heterogeneus disorder of the endocrine reproductive system in women of childbearing age. It affects 4-20% of women in reproductive age worldwide. Our aim was to analyze the epidemiological disease burden of PCOS in Hungary between 2010 and 2019.

METHODS: Data were derived from the financial database of the Hungarian National Health Insurance Fund Administration, for the year 2010 and 2019. Database included annual number of patients number of cases and the prevalence of the utilization according to age groups in 100,000 inhabitants. The following health insurance treatment categories were included into our study: general practitioner care, home care, in- and outpatient care, medical imaging, laboratory diagnostics, pharmaceuticals and medical aids. Patients with polycystic ovary syndrome were identified with the following code of the International Classification of Diseases 10^th revision: E28.2.

RESULTS: The highest number of patients were found in outpatient care (2010: 11,900; 2019: 12,832), followed by general practitioner care (2010: 2,882; 2019: 6,876). Based on the number of patients related to outpatient care the prevalence among women was 119.8 in 2010, while 131.3 in 100,000 inhabitants in 2019. Age-specific prevalence was the highest within the age group of ’20-29’ (971.6 women). It was followed by the 30-39 years (449.1) in 2010. In 2019 the prevalence was remarkably increased in the ’20-29’ (1,137.2) and ’40-49’ age groups (579.1). The mean age of the patients in outpatient care was 28.0 years in 2010 and 29.3 years in 2019.

CONCLUSIONS: The most significant increase in the number of patients was in the general practitioner care (2.4 times) and laboratory diagnostics (1.4 times). The mean age increased by 1.3 years in the study period, furthermore, the highest increase of number of patient was in ’40-49’ age group (1.9 times).